After Hours Summary: JCOM +14%, ICUI +6.8% up on earnings; PFNX +59.5% to be acquired; TLRY -10%, OMER -9.8% lower on earningsAfter Hours Gainers:
Companies trading higher in after hours in reaction to earnings/guidance: SCOR +19.8%, KFRC +15.8%, JCOM +14%, GSKY +13.6%, QRTEA +7.4%, ICUI +6.8% (also signs long-term US distribution deal with GRFS), DHT +5.5%, UNIT +4.6%, CSOD +4.2%, STAY +4%, ADUS +3.6%, IART +3.3%, MESA +3.2%, NHI +2.7%, GO +2.4%, WES +2.4%, TME +2.2%, TCO +2.1%, ESPR +1.9%, ADPT +1.7%, NTR +1.7%, ADVM +1.7%, XPER +1.4%, PRA +0.5%, KAMN +0.3%
Companies trading higher in after hours in reaction to news: PFNX +59.5% (to be acquired by LGND), EQ +31.3% (announces "positive" interim data with itolizumab in EQUATE study), MVC +15% (to merge with BBDC), GNSS +7.4% (to acquire of Amika Mobile; also files for mixed shelf offering), ADVM +4.2% (positive interim data from Phase 1 Trial of ADVM-022), TME +2.2% (Tencent Music and Universal Music announce multi-year extension of licensing agreement), BBDC +1.2% (to merge with MVC), CALA +0.8% (files for $250 mln mixed shelf offering), QDEL +0.6% (says Maryland now allows for COVID testing even without symptoms), CFG +0.4% (Fed has decided not to change prior decision on DFAST ruling), QGEN +0.2% (announces new commercialization and distribution agreement with HTGM), GD +0.2% (awarded $430 mln Army contract), CNS +0.1% (reports July assets under mgmt), GPK +0.1% (announces second $250 mln acquisition of IP's minority partnership interest), AMK +0.1% (issues July report), CUK +0.1% (announces upcoming voyage cancellations for three Seabourn ships)
After Hours Losers:
Companies trading lower in after hours in reaction to earnings/guidance: NGL -12.9%, TLRY -10%, OMER -9.8% (also announces stock offering), IPAR -9.6%, IFF -7.5%, INO -7.4%, ANGI -5.8%, OXY -5.8%, CNXN -5.7%, QLYS -5.2%, IAC -3.5%, ZI -3.5%, HALO -3.1%, NSTG -3%, RAMP -1.4%, SPG -0.9%, RUN -0.8%, AKBA -0.7%, RPAY -0.6%, ESE -0.1%
Companies trading lower in after hours in reaction to news: SPT -6.3% (stock offering), SDGR -5.1% (stock offering), BBBY -4.8% (lifts suspension of planned debt reduction; also says July comps were posiitve), OCFT -3.6% (stock offering), PRFT -3.5% (convertible notes offering), GTT -2.7% (delays 10-Q filing), AVYA -2.6% (stock offering), LYFT -2.1% (unfavorable court ruling in California case), NVAX -2.1% (expands partnership with AGC Biologics), UPLD -2.1% (stock offering), UBER -1.5% (unfavorable court ruling in California case), KKR -1.4% (convertible preferred offering), FTK -1.3% (delays 10-Q filing), W -1.3% (convertible offering), FND -0.8% (stock offering), NTES -0.5% (NetEase Cloud Music enters into licensing agreement with Universal Music Group in China), ADAP -0.4% (files for $200 mln mixed shelf offering), FE -0.2% (delays 10-Q filing), MTCH -0.2% (files mixed securities shelf offering)
- Infineon (IFX TH) +1.7%
- Deutsche Bank (DBK TH) +1.4%
- Bayer (BAYN TH) +1.3%
- VW (VOW3 TH) +1.2%
- Adidas (ADS TH) +1.2%
- Wirecard (WDI TH) -2.5%
- HelloFresh (HFG TH) +8.6%
- HelloFresh 2Q Adj. Ebitda Margin 15.8%, Sees FY Margin of 9%-11%
- Zalando (ZAL TH) +3.5%
- Zalando 2Q Adjusted Ebit EU211.9 Mln Vs. EU101.7 Mln Y/y
- K+S (SDF TH) +2.2%
- Evotec SE (EVT TH) +1.9%
- Alstria Office (AOX TH) +1.7%
- Suedzucker (SZU TH) +2.8%
- Suedzucker Raised to Buy at Commerzbank; PT 19 euros
- Hamburger Hafen (HHFA TH) +2.7%
- Steinhoff (SNH TH) +2.3%
- Borussia Dortmund (BVB TH) +1.7%
- Dortmund Will Not Let ManU Target Jadon Sancho Leave the Club
- Salzgitter (SZG TH) +1.4%
- Corestate (CCAP TH) -0.7%
- Corestate First Half Ebitda EU25.9 Mln, -62% Y/y
- Deutz (DEZ TH) -2.2%
- Deutz Second Quarter Adjusted Ebit Margin -13.6%
Gapping down
In reaction to disappointing earnings/guidance:
- RETA -8.5%, SEAS -5.4%, MAR -2.6%, RDN -2%, GVA -1.3%, FOLD -0.5%
Other news:
- XFOR -1.8% (files for $150 mln mixed securities shelf offering)
- HCM -1.1% (receives Scientific Advice from EMA's CHMP; plans to submit Marketing Authorization Application for Surufatinib) .
Analyst comments:
- TS -1.7% (downgraded to Underweight from Equal Weight at Barclays)
- TRUP -1.6% (downgraded to Neutral from Buy at Guggenheim)
- OLN -1.2% (downgraded to Neutral from Buy at BofA Securities)
- RYN -0.6% (downgraded to Neutral from Buy at Citigroup)
Gapping up
In reaction to strong earnings/guidance:
- FL +20.5%, GOGO +11.4%, CEVA +9.5%, CGC +8%, SDGR +6.5%, AVYA +6.1%, TGNA +5%, ICPT +4.6%, TGTX +3.7%, AXSM +3.1%, WSC +2.2%, GOLD +1.9%, DUK +1.6%, ON +1.5%, MNTA +1.1%
Other news:
- MCRB +311.9% (announces positive topline results from SER-109 Phase 3 ECOSPOR III study)
- TRVN +55% (announces FDA approval of OLINVYK (oliceridine) injection)
- MJCO +22.6% (to be acquired by Thoma Bravo for $16.00 per share)
- IBIO +13.2% (provided an update on one of its proprietary vaccine candidates being designed to prevent infection from the SARS-CoV-2 virus)
- DOYU +11.5% (reported earnings, also - received a preliminary non-binding proposal letter, dated August 10, 2020, from Tencent Holdings Limited, proposing that DouYu and HUYA Inc. (HUYA) enter into a stock-for-stock merger)
- MNK +7.6% (announces U.S. FDA filing acceptance of Biologics License Application for StrataGraft regenerative skin tissue for treatment of adults with deep partial-thickness thermal burns)
- HUYA +7.3% (received a preliminary non-binding proposal letter, dated August 10, 2020, from Tencent Holdings Limited, proposing that DouYu and HUYA Inc. (HUYA) enter into a stock-for-stock merger)
- SNCR +6.2% (secured a renewal to its agreement to provide Verizon with its White-Label Personal Cloud Platform)
- SPG +6.1% (Simon Property Group (SPG) is in discussions with Amazon (AMZN) to turn some of its anchor store space into fulfillment centers)
- PSTI +5.9% (Paul Ehrlich Institutehas cleared the Company's Phase II clinical protocol for its study to Evaluate the Efficacy and Safety of Intramuscular Injections of PLX PAD for the Treatment of severe COVID-19)
- NK +5.4% (NantKwest and CBR by Generate Life Sciences announce collaboration to develop a COVID-19 treatment leveraging newborn stem cells
- TWTR +3.3% (Twitter (TWTR) and TikTok held preliminary discussions about a potential merger )
- AQST +3.3% (FDA has granted Fast Track designation for the Company's drug candidate AQST-108 for the treatment of allergic reactions (Type 1), including anaphylaxis)
- AXSM +3.1% (announces continued progress toward NDA filing of AXS-05 in the treatment of major depressive disorder)
- AAPL +1.2% (positive article in Barrons)
Analyst comments:
- AVNT +7.8% (upgraded to Buy from Hold at The Benchmark Company)
- FVRR +3.5% (upgraded to Buy from Neutral at Citigroup)
- FDX +1.9% (upgraded to Outperform from Mkt Perform at Bernstein)
- KRMD +1.6% (initiated with a Buy at H.C. Wainwright; tgt $16)
- CUBE +1% (upgraded to Outperform from In-line at Evercore ISI)
Early premarket gappers
- Gapping up:
- MCRB +173.3%, TRVN +68.9%, MJCO +22.2%, FL +17.3%, SNCR +16%, DOYU +9.3%, SDGR +6.7%, SPG +6%, WSC +4.4%, FSLY +3%, TWTR +2.9%, ON +2.4%, GOLD +1.6%, AJRD +1.1%, AAPL +1%, BRK.B +0.9%
- Gapping down:
- SEAS -5.4%, RETA -4.9%, CYCN -2.5%, RDN -2%, HCM -1.1%, VXX -0.5%, GILD -0.5%